AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Talwar, S. A
Right arrow Articles by Yeh, J. K
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talwar, S. A
Right arrow Articles by Yeh, J. K
Agricola
Right arrow Articles by Talwar, S. A
Right arrow Articles by Yeh, J. K
American Journal of Clinical Nutrition, Vol. 86, No. 6, 1657-1662, December 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dose response to vitamin D supplementation among postmenopausal African American women1,2,3

Sonia A Talwar, John F Aloia, Simcha Pollack and James K Yeh

1 From the Bone Mineral Research Center, Winthrop University Hospital, Mineola, NY

Background: Reports on the dose response to vitamin D are conflicting, and most data were derived from white men and women.

Objective: The objective was to determine the response of serum 25-hydroxyvitamin D [25(OH)D] to oral vitamin D3 supplementation in an African American population.

Design: Healthy black postmenopausal women (n = 208) participated in a vitamin D3 supplementation trial for a period of 3 y. Analyses were done in the vitamin D supplementation arm (n = 104) to quantify the response in serum 25-hydroxyvitamin D concentrations at a steady state vitamin D input. The participants received 20 µg/d (800 IU) oral vitamin D3 for the initial 2 y and 50 µg/d (2000 IU) for the third year.

Results: Supplementation with 20 µg/d (800 IU/d) vitamin D3 raised the mean serum 25(OH)D concentration from a baseline of 46.9 ± 20.6 nmol/L to 71.4 ± 21.5 nmol/L at 3 mo. The mean (±SD) concentration of serum 25(OH)D was 87.3 ± 27.0 nmol/L 3 mo after supplementation increased to 50 µg/d (2000 IU/d). All participants achieved a serum 25(OH)D concentration >35 nmol/L, 95% achieved a concentration >50 nmol/L, but only 60% achieved a concentration >75 nmol/L. All patients had concentrations <153 nmol/L. On the basis of our findings, an algorithm for prescribing vitamin D so that patients reach optimal serum concentrations was developed. The algorithm suggests a dose of 70 µg (2800 IU/d) for those with a concentration >45 nmol/L and a dose of 100 µg (4000 IU/d) for those with a concentration <45 nmol/L.

Conclusions: Supplementation with 50 µg/d (2000 IU/d) oral vitamin D3 is sufficient to raise serum 25-hydroxyvitamin D concentrations to >50 nmol/L in almost all postmenopausal African American women. However, higher doses were needed to achieve concentrations >75 nmol/L in many women in this population.

Key Words: Ethnicity • vitamin D • 25-hydroxyvitamin D • osteoporosis • vitamin D deficiency • African Americans







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition